Book your Miboflo Treatment today!
How Common is Dry eye?
Per clinical studies, dry eye disease is becoming more common within the average patient population. It is affecting as many as 1 in every 4 patients presenting to general eye clinics. Associated risk factors include female sex, electronic device use, contact lens wear, Lasik surgery, autoimmune disease and hormonal dysfunction.
Miboflo is a one of a kind treatment is that is Comfortable, Relaxing, Effective, and Safe.
This treatment is FSA & HSA eligible.
Author: Dr. Josephine Ko, OD, FAAO
References
Maria-laura Gomez, Natalie a. Afshari, Daisy d. Gonzalez, Lingyun Cheng, Effect of Thermoelectric Warming Therapy for the Treatment of Meibomian Gland Dysfunction, American Journal of Ophthalmology, Volume 242, 2022, Pages 181-188 https://doi.org/10.1016/j.ajo.2022.06.013.
Gayton, J. L. (2009). Etiology, prevalence, and treatment of dry eye disease. Clinical Ophthalmology, 3, 405–412. https://doi.org/10.2147/opth.s5555
Fiona Stapleton, Monica Alves, Vatinee Y. Bunya, Isabelle Jalbert, Kaevalin Lekhanont, Florence Malet, Kyung-Sun Na, Debra Schaumberg, Miki Uchino, Jelle Vehof, Eloy Viso, Susan Vitale, Lyndon Jones, TFOS DEWS II Epidemiology Report, The Ocular Surface, Volume 15, Issue 3, 2017, Pages 334-365, ISSN 1542-0124, https://doi.org/10.1016/j.jtos.2017.05.003.